Back to resultsEvaluation of a Desipramine Ceiling in Cocaine Abuse - 1
Primary Purpose
Cocaine-Related Disorders, Substance-Related Disorders
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Desipramine
Sponsored by
About this trial
This is an interventional treatment trial for Cocaine-Related Disorders focused on measuring cocaine dependence
Eligibility Criteria
Please contact site for information.
Sites / Locations
- Friends Research Institute
Outcomes
Primary Outcome Measures
Craving
Retention
Cocaine use
Depression
Anxiety
Mood indicators
Secondary Outcome Measures
Full Information
NCT ID
NCT00000245
First Posted
September 20, 1999
Last Updated
January 11, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Friends Research Institute, Inc.
1. Study Identification
Unique Protocol Identification Number
NCT00000245
Brief Title
Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
Official Title
Evaluation of a Desipramine Ceiling in Cocaine Abuse
Study Type
Interventional
2. Study Status
Record Verification Date
November 2016
Overall Recruitment Status
Completed
Study Start Date
May 1994 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 2001 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Friends Research Institute, Inc.
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to confirm whether a blood level ""ceiling"" exists on desipramine effect in cocaine abuse.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders, Substance-Related Disorders
Keywords
cocaine dependence
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Enrollment
0 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Desipramine
Primary Outcome Measure Information:
Title
Craving
Title
Retention
Title
Cocaine use
Title
Depression
Title
Anxiety
Title
Mood indicators
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Frank Gawin, M.D.
Organizational Affiliation
Friends Research Institute, Inc.
Official's Role
Principal Investigator
Facility Information:
Facility Name
Friends Research Institute
City
Los Angeles
State/Province
California
ZIP/Postal Code
90025
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
We'll reach out to this number within 24 hrs